Evidence map›Paper›PMID 30203376›Full record

ReviewCurrent rheumatology reports2018

Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: Prevention and Diagnosis.

Ajay Premkumar, Kyle Morse, Ashley E Levack, Mathias P Bostrom, Alberto V Carli

Abstract readReview
In one paragraph

Review in Current rheumatology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Synovial fluid dual-biomarker algorithm accurately differentiates osteoarthritis from inflammatory arthritis.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article
  8. Article
  9. Article
  10. Periprosthetic Joint Infection (PJI).The archives of bone and joint surgery · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Role of Biomarkers in Periprosthetic Joint Infections.Diagnostics (Basel, Switzerland) · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ajay PremkumarDepartment of Academic Training, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA.
Kyle MorseDepartment of Academic Training, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA.
Ashley E LevackDepartment of Academic Training, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA. levacka@hss.edu.
Mathias P BostromDepartment of Academic Training, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA.
Alberto V CarliDepartment of Academic Training, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA.
Hospital for Special Surgery · US

Funding

ORTHOPAEDIC RESEARCH TRAININGT32AR007281 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI MAHER, SUZANNE A., VAN DER MEULEN, MARJOLEIN C · 1986 to 2018
$1.8M
NIAMS NIH HHS T32 AR007281
6 · The paper itself

Abstract

purpose of reviewPeriprosthetic joint infection (PJI) is a devastating complication that can occur following total joint arthroplasty (TJA), causing significant morbidity and often requiring revision surgery. This goal of this manuscript is to review the current evidence for the prevention and diagnosis of PJI in patients with inflammatory arthritis. RECENT

findingsPatients with inflammatory arthritis have a higher risk of PJI after TJA; however, there are several preventive, diagnostic, and therapeutic measures that can be optimized to lower the burden of PJI in this population. This manuscript will review the current evidence and clinical practice recommendations that support specific features of preoperative evaluation, perioperative medication management, and surgical planning in inflammatory arthritis patients undergoing TJA. Evidence and recommendations for the diagnosis of PJI in this patient population will also be reviewed. Despite increased research efforts directed towards PJI, specific approaches directed at the inflammatory arthritis patient population remain surprisingly limited. Optimization strategies such as adequately managing disease-modifying medications, treating preoperative anemia, encouraging smoking cessation, and improving weight management are strongly encouraged before entering the perioperative period. If PJI does occur in the inflammatory arthritis patient, establishing the diagnosis is challenging, since guidelines were created from investigations of PJI in primarily patients without inflammatory arthritis. Future prospective research is required to better guide clinicians in preventing and diagnosing PJI in inflammatory arthritis patients undergoing TJA.

Indexed as

Arthroplasty, Replacement, HipArthritisArthritis, RheumatoidBiomarkersEvidence-Based MedicineHumansInflammation MediatorsPerioperative CareProsthesis-Related InfectionsBiomarkersInflammation MediatorsInflammatory arthritisPeri-operative managementProsthetic joint infectionRheumatoidTotal hip arthroplastyTotal knee arthroplasty

Identifiers

PMID30203376
PMCPMC6543529
OpenAlexW2892033644

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.